Pharmaceuticals in Scandinavia [Report Updated: 30062017] Prices from USD $350

11:19 EDT 5 Jul 2017 | BioPortfolio Report Blog

Pharmaceuticals in Scandinavia


Pharmaceuticals in Scandinavia industry profile provides topline qualitative and quantitative summary information including: market share, market size value 201216, and forecast to 2021. The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.


Essential resource for topline data and analysis covering the Scandinavia pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key Highlights

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at exfactory prices the value at which manufacturers sell the drugs to distributors. Any currency conversions used in the production of this report have been calculated at constant 2016 annual average exchange rates.
The Scandinavian pharmaceuticals market had total revenues of $11.5bn in 2016, representing a compound annual growth rate CAGR of 3.7% between 2012 and 2016.
Sweden is the largest of the four markets but trends have been noticed that manufacturing appears to be shifting slightly in favour of Denmark in the region which may have an effect on local retail sales and government policy perhaps boosting growth in the future.
The four Scandinavian component countries are heavily driven by a large government public health market and they have been affected by the trend of western governments to cutting down on pharmaceutical spending, instead trying to encourage greater adoption of generics and cheaper alternatives.


Save time carrying out entrylevel research by identifying the size, growth, and leading players in the pharmaceuticals market in Scandinavia
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Scandinavia
Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Scandinavia pharmaceuticals market with five year forecasts

Reasons to buy

What was the size of the Scandinavia pharmaceuticals market by value in 2016?
What will be the size of the Scandinavia pharmaceuticals market in 2021?
What factors are affecting the strength of competition in the Scandinavia pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitiors in Scandinavia's pharmaceuticals market?

Original Article: Pharmaceuticals in Scandinavia [Report Updated: 30062017] Prices from USD $350


More From BioPortfolio on "Pharmaceuticals in Scandinavia [Report Updated: 30062017] Prices from USD $350"

Quick Search


Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...